# Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.

> **NCT06218602** · PHASE2 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 40 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** Fecal Microbiota Transplantation
- **PROCEDURE:** Chemotherapy
- **PROCEDURE:** CAR-T Therapy

## Key facts

- **NCT ID:** NCT06218602
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-19
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06218602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06218602, "Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06218602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*